First human test of DNA therapy for tough cancers begins
NCT ID NCT06736275
Summary
This is a very early study to see if a new experimental treatment called SXRN is safe for people with advanced solid tumors. It will test different doses in a small group of patients who have no other effective treatment options left. The main goal is to find the highest dose that can be given safely and to see how the body processes the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CACHEXIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, 100021, China
Conditions
Explore the condition pages connected to this study.